TG Therapeutics, Inc.
TGTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | $28 | $5 | $23 |
| Dep. & Amort. | – | $0 | $0 | $0 |
| Deferred Tax | – | $0 | $0 | $0 |
| Stock-Based Comp. | – | $16 | $15 | $12 |
| Change in WC | – | -$37 | -$49 | -$61 |
| Other Non-Cash | – | -$0 | -$0 | -$0 |
| Operating Cash Flow | – | $7 | -$29 | -$26 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | -$0 | -$0 | -$0 |
| Net Acquisitions | – | $0 | $0 | $0 |
| Inv. Purchases | – | -$53 | -$93 | -$58 |
| Inv. Sales/Matur. | – | $49 | $80 | $74 |
| Other Inv. Act. | – | $0 | $0 | $0 |
| Investing Cash Flow | – | -$4 | -$13 | $16 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | $0 | $0 | $0 |
| Stock Issued | – | $0 | $0 | $0 |
| Stock Repurch. | – | -$7 | -$6 | -$7 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | $0 | $0 | $1 |
| Financing Cash Flow | – | -$6 | -$6 | -$6 |
| Forex Effect | – | $0 | $0 | $0 |
| Net Chg. in Cash | – | -$3 | -$48 | -$16 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $133 | $181 | $197 |
| End Cash | – | $130 | $133 | $181 |
| Free Cash Flow | – | $7 | -$29 | -$26 |